Research

Hormonal

Circulating miR-19a/b and miR-125b are associated with features of metabolic syndrome and cardiovascular disease risk, including biomarkers of atherosclerosis.

Elevated levels of miR-19a/b and miR-125b in the blood may signal an increased risk of cardiovascular issues and metabolic dysfunction in people with fatty liver. This suggests that liver health is closely tied to heart health, and monitoring these markers could help assess overall metabolic risk.

GoodSupportsHIGH confidence
Circulating miR-19a/b and miR-125b were correlated with biomarkers of atherosclerosis.
Carlos J. Pirola et al. · Gut · 2014

Why this rating

Validated in an independent replication set with significant associations to clinical parameters.

Source

Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis

Carlos J. Pirola et al. · Gut · 2014

DOI 10.1136/gutjnl-2014-306996

case_control · n=248Cited 548×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →